 |
|
(LEH-vulz uv EH-vih-dents)
| | A ranking system used to describe the strength of the results measured in a clinical trial or research study. The design of the study (such as a case report for an individual patient or a randomized double-blinded controlled clinical trial) and the endpoints measured (such as survival or quality of life) affect the strength of the evidence. |
| Previous Definitions: | leukoplakia, leuprolide, leuprolide acetate, leuvectin, levamisole | | Next Definitions: | levetiracetam, levocarnitine, levofloxacin, levonorgestrel, Levulan |
|
|
